X

Trial Profile

Pharmacokinetics of a Single Oral Dose of Maxmarvil; in Healthy Postmenopausal Women Without a Previous History of Fractures.

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Alendronic acid/colecalciferol (Primary)
Indications Postmenopausal osteoporosis
Focus Pharmacokinetics

Most Recent Events

25 Feb 2019 Biomarkers information updated
13 Feb 2013 Planned End Date changed from 1 Sep 2012 to 28 Sep 2012 as reported by Korean Clinical Trials Register record.
14 Mar 2012 New source identified and integrated (KCT0000362; Clinical Research Information Service (CriS) - Republic of Korea).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com